"I'm thrilled to partner once again with the Lilly Pulitzer brand for our Valentine's Day capsule showcasing coordinating ...
Lawyers for the board that awards Pulitzer Prizes asked a Florida state court to pause the defamation lawsuit President Trump filed against board members in 2022 until Trump is no longer president.
Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...
On Monday, the board that awards the Pulitzer Prizes — which Mr. Trump sued in Florida in 2022 for defamation — said that the case should be put on hold because, as Mr. Trump has argued in two ...
In “Lilly,” writer-director Rachel Feldman follows the era-defining work of one such everyday woman: trailblazer Lilly Ledbetter, a pioneer from humble beginnings who took her employer ...
Eli Lilly & Co.’s fourth-quarter revenue fell short of analysts’ estimates as the drugmaker struggled to forecast demand for its popular weight-loss and diabetes shots for the second quarter ...
Ricks, Lilly chair and CEO. "The rest of our medicines performed within our expectations." "2024 was a pivotal and highly successful year for Lilly, and we expect to continue our momentum in 2025 ...
Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.
SAN FRANCISCO — Eli Lilly said Monday it would acquire a cancer program from startup Scorpion Therapeutics in a deal worth up to $2.5 billion, as the Indianapolis company broadens its pipeline.
Jan 13 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it plans to buy Scorpion Therapeutics' experimental cancer therapy for up to $2.5 billion in cash to expand its pipeline of ...
In the new filing, Lilly says it wants to wade into the legal proceedings to “protect its interests and help bring this suit to a swift end.” The company’s lawyers further contend that OFA ...
Lawyers for the Pulitzer Prize Board have asked a judge to pause President Donald Trump's defamation lawsuit against its members, using the Republican's own legal arguments as part of his defense ...